Skip to content
    DeepWork Capital logo

    DeepWork Capital

    Orlando, Florida, United StatesFounded 2015
    www.deepworkcapital.comLinkedIn
    Biotech & Life SciencesHealthcareSaaSEnterprise SoftwareFintechConsumerClimate & EnergyDefense & Space

    DeepWork Capital is an early-stage venture capital firm based in Orlando, Florida, founded in 2015. It invests in high-growth, tech-forward companies across technology and life sciences sectors, with a focus on underserved U.S. markets.

    Their most common stage is seed (44% of deals). Average disclosed round size is $25.4M (across 21 rounds with reported amounts).

    Find people at DeepWork Capital on Goldilocks AI

    Portfolio

    21

    Fund Size

    $150M

    Top Stage

    Seed

    Last 12 Mo

    4

    Team

    Ben Patz

    Ben Patz

    Managing Partner

    Kathy Chiu

    Kathy Chiu

    Managing Partner

    Mitchel Laskey

    Mitchel Laskey

    Managing Partner

    Jackson Streeter, MD

    Jackson Streeter, MD

    Venture Partner

    Ken Hall

    Ken Hall

    Partner

    Mona Patel

    Mona Patel

    Director of Platform Success

    TJ Fleming

    TJ Fleming

    Vice President

    Tom McNamara

    Tom McNamara

    Vice President

    Kristopher Lancaster

    Kristopher Lancaster

    Associate

    Nam Nguyen

    Nam Nguyen

    Investor and Community Relations Specialist

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    25 investments
    CompanyRoundAmountDate
    Tenex AI logoTenex AISeries B$250MApr 2026
    Tenex AI logoTenex AISeries C—Mar 2026
    FirmPilot logoFirmPilotSeries A$22MFeb 2026
    Irys logoIrysSeed$12.5MOct 2025
    Palla logoPallaSeries A—May 2025
    Exowatt logoExowattSeries A$50MApr 2025
    Worth AI logoWorth AISeed$20MMar 2025
    Myosin Therapeutics logoMyosin TherapeuticsSeed$3MFeb 2025
    Exowatt logoExowattSeries A$50MJan 2025
    IIrys InsurtechSeed$12.5MJan 2025
    Cyrano Therapeutics, Inc. logoCyrano Therapeutics, Inc.Series B$9MJan 2024
    Myosin Therapeutics logoMyosin TherapeuticsSeed—Mar 2023
    JourneyTrack logoJourneyTrackSeed$1.5MJan 2023
    Genascence logoGenascenceSeries A$10.5MMay 2022
    UrbanSDK logoUrbanSDKSeed$4.5MJan 2022
    Lucy Labs logoLucy LabsUnknown$3MDec 2021
    Astrocyte logoAstrocyteSeries A$6MMay 2021
    Vesteck logoVesteckSeries A$4.3MJan 2021
    Aegle Therapeutics logoAegle TherapeuticsSeries A$6.5MSep 2020
    Xendoo logoXendooSeed$3.5MOct 2019
    TAO Connect logoTAO ConnectUnknown$1.1MJan 2016
    Mobilo logoMobiloSeed$4.1M—
    HHCW BIologicsIpo$56M—
    Biota logoBiotaSeed$3M—
    Genascence logoGenascenceSeed——

    Top Co-Investors

    Florida Opportunity Fund10 shared
    Andreessen Horowitz (a16z) Bio + Health3 shared
    Techstars2 shared
    Atlas Venture2 shared
    Dragon Capital2 shared
    8090 Industries2 shared
    Atomic2 shared
    MVP Ventures2 shared
    Protagonist2 shared
    Overmatch Ventures2 shared
    StepStone Group2 shared
    BAM2 shared
    Ally Bridge Group2 shared
    BAM Ventures2 shared
    Felicis2 shared
    Florida Funders2 shared
    Shield Capital2 shared
    Crosspoint Capital Partners2 shared
    Markd2 shared
    Gaingels1 shared

    Last updated: 20 October 2026